Case Report
Published on 09 Oct 2024
Extraordinary therapeutic effect of PSMA radioligand therapy in treatment-refractory progressive metastatic prostate cancer with the transketolase inhibitor benfo-oxythiamine as a radiosensitizer—A case report
in Nuclear Medicine
Frontiers in Medicine
doi 10.3389/fmed.2024.1462234
- 4,525 views
- 3 citations


